Third-Party Peptide Testing, Explained: Who Actually Verifies Your Vial

A vendor tells you a vial is 99% pure. The obvious question is how they know. The better question is who checked their work. Third party peptide testing exists because the answer to the first question is worthless without an answer to the second. This article walks through what an independent testing lab actually does, what chain of custody means in practice, why a vendor's in-house numbers are data but not verification, and how to confirm that the Certificate of Analysis in front of you is real.

What an independent testing lab actually does

A third party lab is a contract analytical facility with no financial stake in the sample passing. The vendor pays for the analysis, not for the answer. That distinction is the entire point.

When a research peptide arrives at a testing lab, the workflow is unglamorous. The sample is logged, assigned an internal identifier, and stored under controlled conditions until analysis. An analyst weighs out a portion, dissolves it in a defined solvent system, and runs it through the instruments the vendor requested. For peptides, the core assay is reversed-phase HPLC, usually on a C18 column with UV detection near 214 nm, the wavelength where the peptide bond absorbs. The instrument separates the sample into components, and software integrates the peaks. The main peak's share of total peak area becomes the chromatographic purity figure.

Identity is a separate assay. Mass spectrometry, typically ESI or MALDI-TOF, measures the molecular mass of the main component and compares it against the theoretical mass of the target sequence. A lab may also run water content by Karl Fischer titration or peptide content by amino acid analysis, if the client pays for it.

The lab then issues a report. A real report names the lab, the method, the instrument parameters, the sample identifier, and the date. It is signed or electronically authorized by an analyst or QC reviewer. It does not editorialize. If the main peak came in at 97.4%, the report says 97.4%, and the vendor has a problem.

That last sentence matters. An independent lab reports what it measures. A vendor reporting on its own product has a reason to round up, rerun, or quietly select the best run. The lab does not. If you want a longer treatment of what those instruments measure and where each one stops, we cover it in our guide to HPLC and mass spectrometry.

Chain of custody, in plain terms

Chain of custody is the documented path a sample travels from the production lot to the instrument. It answers one question: is the material on the report the same material in your vial?

A defensible chain looks like this. A specific lot is manufactured and assigned a lot number. Vials from that lot are pulled, labeled with the lot number, sealed, and shipped to the lab with documentation. The lab logs receipt, records the condition of the package, and assigns its own sample ID that maps back to the vendor's lot number. Every transfer is recorded. The final report carries both identifiers.

Where does this break down? A few common failure points are worth knowing.

• Cherry-picked samples. A vendor sends a hand-selected vial rather than a randomly pulled one. The lab can only test what arrives. This is why per-lot testing matters more than a single flattering report from months ago.
• Orphaned reports. A COA with no lot number, or a lot number that does not match the vial label, verifies nothing. It is a document about some other material.
• Stale data. A report from a previous lot presented as if it covers the current one. Peptide synthesis is lot by lot. So is verification.

None of this requires bad faith to go wrong. It only requires sloppiness. The fix is boring discipline: one lot, one sample pull, one report, all carrying the same number.

Why in-house numbers are not verification

Plenty of vendors run their own analytical HPLC. That is good practice and we have no quarrel with it. In-house QC catches failed syntheses before they ship, and a vendor without any internal instrumentation is flying blind.

But in-house data is process control, not verification. The difference is structural, not personal. Verification requires that the party measuring has nothing riding on the outcome. A vendor's own chromatogram fails that test by definition, no matter how honest the operator is. There is no audit trail a customer can inspect, no external analyst accountable for the number, and no cost to quietly re-integrating a baseline until the purity clears the spec.

Peptide testing labs solve this by being contractually indifferent. Their business depends on the accuracy of their reports across hundreds of clients, not on any one sample passing. When a vendor publishes an independent report alongside its own numbers, the two should agree within normal method variability. When a vendor publishes only its own numbers, you are reading a claim, not a measurement you can lean on.

Our position at New England Peptide Center follows from that logic. Every lot we sell is tested by an independent third party lab using HPLC, and every lot must meet a minimum of 99.0% chromatographic purity before it is listed in our research peptide catalog. We do not treat that as a marketing feature. We treat it as the minimum condition for asking a laboratory buyer to trust the label.

How to confirm a COA is real

A PDF with a purity number on it is not evidence. It is a claim in a nicer font. COA verification is the process of checking that the document traces to a real analysis of the lot you hold. Here is a practical checklist.

• Match the lot number. The lot on the COA must match the lot printed on your vial. No match, no verification. This is the first check and it filters out most problems.
• Identify the lab. The report should name the testing facility. Look the lab up. It should exist, do contract analytical work, and be reachable. A COA with a vendor logo and no lab name is an in-house document, whatever the header says.
• Check the method details. A real chromatography report states the column, mobile phase or gradient, detection wavelength, and sample load parameters, and usually includes the chromatogram itself. A bare number with no method is not a report. Read the paper, not the summary line.
• Confirm identity data separately. Purity and identity are different measurements. A complete verification package includes a mass spec result showing the observed mass against the theoretical mass for the sequence.
• Check the date. The analysis date should sit sensibly between the lot's production and its sale. A report that predates the lot is describing something else.
• Verify with the source when it matters. For work where the stakes justify it, contact the testing lab and ask them to confirm the report number is genuine. Legitimate labs answer this question. Illegitimate documents do not survive it.

We keep every current report in our Certificate of Analysis Library, organized by product and lot, so this checklist can be run without emailing anyone. If a lot is on sale and its COA is not posted, ask us for it. If any vendor cannot produce a lot-matched COA on request, that silence is itself a data point.

The short version

Independent testing is not a luxury feature of the research peptide market. It is the only mechanism by which a purity claim becomes a purity measurement. A trustworthy verification chain has four links: a named third party lab, a documented chain of custody tied to a lot number, method-level detail you can read, and a report you can trace back to its source. Any vendor can print 99%. The question is always who measured it, on which lot, and whether you can check. Our terms spell out what we guarantee and what we do not, in writing, because that is where guarantees belong.

All products discussed are for in-vitro laboratory research use only and are not for human or animal use. Nothing here is medical, legal, or purchasing advice.